Nature's Miracle Aktie Logo
US63903P2092
A40N0K

Nature's Miracle Aktie

Cargando cotizaciones...

Previsión

No hay datos de analistas disponibles para esta empresa.


  • Nature’s Miracle enters partnership with FF AI-Robotics for robotics deployment in North America

    Nature’s Miracle has signed a letter of intent with FF AI-Robotics to support the “Robotics Partnership Program” in North America. The partners plan to build a network of showrooms, operations and service centers; Nature’s Miracle will handle marketing, customer operations and infrastructure development, while FF will provide product training and operational support. Nature’s Miracle has already received deliveries of FF robots, and program participants are expected to be able to earn revenue over the robots’ lifecycle. The company is expanding its focus to robotics and AI infrastructure but faces significant financial problems, including low market capitalization, high debt and a sharply fallen share price. » Más en de.investing.com


  • Nature’s Miracle Holding: Q3‑2025 financial report no longer reliable due to omission of short‑term loans

    Nature’s Miracle Holding said the previously issued unaudited consolidated financial statements and disclosures for the quarter ended September 30, 2025 are no longer reliable due to an omission related to short‑term loans. Management announced it will file an amended Form 10‑Q/A to properly account for the loan and has discussed the matter with its auditors and the audit committee. » Más en de.investing.com


  • Nature’s Miracle settles USD 6.9m debt by issuing shares to Megaphoton

    Nature’s Miracle settles trade payables of USD 6.9 million to Megaphoton by issuing 15 million common shares at USD 0.46 per share (about 13% of share capital) and also reimburses USD 300,000 in legal costs. The transaction ends the lawsuit ongoing since 2022, results in a one‑time gain of USD 6.9 million and increases equity in Q1 2026. Despite the relief, the financial position remains strained: the stock trades around USD 0.05 and the liquidity ratio is only 0.12. » Más en de.investing.com

Datos financieros de la empresa

En el último trimestre, Nature's Miracle Aktie tuvo unos ingresos de +35,94k y un beneficio neto de +2,46M
(EUR) mar 2026
YoY
Ingresos +35,94k 96,49%
Beneficio bruto 144,53k 189,19%
Beneficio neto +2,46M 231,64%
EBITDA 792,76k 11,31%

Datos fundamentales

Métrica Valor
Capitalización bursátil
+17,57k
Número de acciones
20,48M
Máximo/mínimo de 52 semanas
+0,39 - +0,000515
Dividendos No
Beta
0,69
Ratio P/E
0,00
Ratio PEG
0,00
Ratio P/B
0,02
Ratio P/S
+0,03

Perfil de la empresa

Nombre
Nature's Miracle Aktie
CEO
Tie Li
Empleados 11
🍪

Parqet  usa cookies. Más información